HIV: What Every Clinician Needs to Know ARIZONA STATE ASSOCIATION OF PHYSICIAN ASSISTANTS SPRING CONFERENCE BETTIE COPLAN MARCH 2018

Size: px
Start display at page:

Download "HIV: What Every Clinician Needs to Know ARIZONA STATE ASSOCIATION OF PHYSICIAN ASSISTANTS SPRING CONFERENCE BETTIE COPLAN MARCH 2018"

Transcription

1 HIV: What Every Clinician Needs to Know ARIZONA STATE ASSOCIATION OF PHYSICIAN ASSISTANTS SPRING CONFERENCE BETTIE COPLAN MARCH 2018 Overview Overview recent trends in HIV incidence in the U.S. HIV screening & signs & symptoms that should prompt diagnostic testing Referral for management Considerations for managing HIV+ individuals presenting for evaluation & management of non HIV conditions HIV United States Annual incidence of HIV infections fell 18% between 2008 & 2014, from 45,700 to 37,600; new infections in ,792 At end of 2015, 1.1 million persons 13 y/o living with HIV / AIDS [incl.162,500 (15%) undiagnosed] Arizona 780 newly infected in ,464 living with HIV / AIDS 1 is < 2 y/o, 48 are 2 12 y/o (2 with AIDs) CDC 2018 AZ Dept of Health Services 2017 report 1

2 Rates of Diagnoses of HIV Infection among Adults and Adolescents 2016 United States and 6 Dependent Areas N = 40,202 Total Rate = 14.7 Note. Data for the year 2016 are preliminary and based on 6 months reporting delay. Rates of Adults and Adolescents Living with Diagnosed HIV Infection Year end 2015 United States and 6 Dependent Areas N = 988,955 Total Rate = Note. Data are based on address of residence as of December 31, 2015 (i.e., most recent known address). Diagnoses of HIV Infection among Adults and Adolescents, by Sex United States and 6 Dependent Areas 2

3 New HIV Diagnoses in the United States by Age, 2016 CDC: Adults and Adolescents Living with Diagnosed HIV Infection, by Sex and Race/Ethnicity, Year end 2015 United States and 6 Dependent Areas Note. Unknown race/ethnicity is not displayed because it comprises less than 1% of cases. a Includes Asian/Pacific Islander legacy cases. b Hispanics/Latinos can be of any race. Estimated New HIV Infections in the United States by Transmission Category, 2014 CDC: 3

4 New HIV Diagnoses in the United States for the Most-Affected Subpopulations, 2016 CDC: HIV TRENDS IN THE U.S. Incidence declining for several years, now stable / increasing slightly Rates are higher among men than women* year olds with highest rates of new infection African Americans & Hispanic/Latino populations disproportionately affected Highest risk categories: male to male sex; heterosexual sex; IV drug use ARIZONA diseasecontrol/disease integrated services/hiv epidemiology/reports/2017/annualreport.pdf 4

5 diseasecontrol/disease integrated services/hiv epidemiology/reports/2017/annualreport.pdf ARIZONA diseasecontrol/disease integrated services/hiv epidemiology/reports/2017/annualreport.pdf ARIZONA diseasecontrol/disease integrated services/hiv epidemiology/reports/2017/annualreport.pdf 5

6 ARIZONA diseasecontrol/disease integrated services/hiv epidemiology/reports/2017/annualreport.pdf HIV TRENDS IN ARIZONA Incidence declining for several years, now increasing slightly Rates are higher among men than women* year olds with highest rates of new infection African Americans, American Indian, & Hispanic/Latino populations disproportionately affected Highest risk categories: male to male sex; heterosexual sex; IV drug use Screen just about everyone for HIV at least once Everyone years old: voluntary opt out testing Anyone in whom TB treatment is being initiated At each presentation for an STD Annually for patients at risk more often for Men who have Sex with Men (MSM)? Pregnant women CDC: 6

7 Diagnostic testing for HIV more often than you think Opportunistic infections (e.g. fungal infections) & TB Symptoms consistent with established HIV Weight loss Recurrent fever, night sweats Extreme tiredness Lymphadenopathy Diarrhea > 1 week Sores of mouth, anus, genitals Pneumonia Unexplained neurologic symptoms Symptoms consistent with acute HIV (aka acute retroviral syndrome) ACUTE HIV LOOKS LIKE OTHER INFECTIONS Clinical signs/symptoms Fever Adenopathy Sore throat Rash* Mucocutaneous ulcers* Myalgia Arthralgia Headache Diarrhea Nausea/Vomiting Laboratory abnormalities Elevated transaminases(lfts) Leukopenia Diagnosis is usually missed Anemia Thrombocytopenia KNOW WHICH HIV TEST YOU RE USING CDC Updated Recommendations for Lab Testing for HIV: 7

8 KNOW WHICH HIV TEST YOU RE USING If you suspect acute HIV & you only test for antibody, you will miss acute HIV Use antigen/antibody combination test or order HIV RNA test CDC Updated Recommendations for Lab Testing for HIV: Inexpensive / no insurance testing Maricopa County STD Clinic $20: Testing Rapid test available only tests for antibody In AZ, minors can access STD testing without parental consent HIV not explicitly included (may want to send to / or contact County)* *Guttmacher Institute: policy/explore/minors access sti services care/pmtct who hhs cmpntsm1.html 8

9 When to refer / when to treat? Antiretroviral therapy (ART) recommended for all with HIV, incl. those with acute/early infection* *Clinical trial data suggest that individuals treated during early infection experience immunologic & virologic benefits refer asap! Genotypic drug resistance testing performed before initiation of ART will guide selection of ART Patients must be willing / able to commit to lifelong treatment with strict adherence Patients may postpone therapy, can be decided on case by case basis Treatment goal suppress plasma HIV 1 RNA levels to undetectable and adolescent arv/20/acute andrecent early hiv infection Where to refer HIVAZ.ORG Other HIV considerations Possible exposure Unprotected sex with someone who tells you they have HIV (or you think may have HIV) Condom broke or fell off during sex Rape or sexual assault Work related exposure to HIV (e.g. needle stick injury) Sharing needles to inject any type of drug Post Exposure Prophylaxis (PEP) Must start within 72 hours can call local health department HIVAZ.ORG CDC Pre Exposure Prophylaxis (PrEP) Daily medication, Truvada prescribed by HIV specialist 9

10 Seeing patients with HIV CD4 T cell count is king Normal CD4 T cell count is cells per cubic/mm May see thrush May see Kaposi sarcoma at any count People do very well at 350 Hovering around 200 will see opportunistic infections < 200 = AIDS or any CD4 T cell count & 1 of 27 AIDS defining illnesses Pneumocystis jirovecipneumonia (formerly PCP) Kaposi sarcoma Invasive candidiasis (esophagus, trachea) Invasive cervical cancer Others Must consider medications Clue to CD4 T cell count CD 4 T cell < 200 Bactrim DS prophylaxis for Pneumocystis jiroveci pneumonia CD 4 T cell < 100 Bactrim DS prophylaxis for Toxoplasma gondii encephalitis CD 4 T cell < 50 Azithromycin prophylaxis for disseminated Mycobacterium avium complex (MAC) Consider drug interactions New Developments Past (multiple pills multiple times / day) Present (once daily regimens) Future (once weekly regimens) Cancer drugs to treat HIV Berlin patient cured after bone marrow transplant in 2007 HIV vaccine trials ongoing (none currently FDA approved) index/2018/2/15/novel methods to eradicate hiv reservoirs brown berlin patient celebrates decade cured hiv/ myths facts.html 10

11 References & Resources CDC website. HIV/AIDS CDC. Laboratory testing for the diagnosis of HIV infection : updated recommendations HIVAZ.org. Information on local providers & resources Maricopa County Health Department website. STD / HIV Services HIV Arizona Department of Health Services Arizona HIV/AIDS Epidemiology Annual Report diseasecontrol/disease integrated services/hiv epidemiology/reports/2017/annual report.pdf U.S. Department of Health & Human Services. AIDSinfo Guttmacher Institute. Minor s Access to STI Services policy/explore/minors access sti services 11

INTEGRATING HIV INTO PRIMARY CARE

INTEGRATING HIV INTO PRIMARY CARE INTEGRATING HIV INTO PRIMARY CARE ADELERO ADEBAJO, MD, MPH, AAHIVS, FACP NO DISCLOSURE 1.2 million people in the United States are living with HIV infection and 1 in 5 are unaware of their infection.

More information

PREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County

PREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County PREVENTION OF HIV IN THE TIMES OF PREP Daniela Chiriboga, MD Florida Department of Health in Polk County MAKING THE CASE FOR PREVENTION The Epidemic in Florida Population in 2014: 19.6 million (3 rd in

More information

Arizona State Office of Rural Health Webinar Series

Arizona State Office of Rural Health Webinar Series Arizona State Office of Rural Health Webinar Series Mute your phone &/or computer microphone Time is reserved at the end for Q&A Please fill out the post-webinar survey Webinar is being recorded Recording

More information

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission Chapter 55 Care of the Patient with HIV/AIDS All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. History of HIV Remains somewhat obscure The earlier

More information

Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft:

Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft: Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft: 10-2-2015 Clinical studies demonstrate that when a person without HIV infection takes

More information

OI prophylaxis When to start, when to stop. Eva Raphael, MD MPH Family and community medicine, pgy-2 University of California, San Francisco

OI prophylaxis When to start, when to stop. Eva Raphael, MD MPH Family and community medicine, pgy-2 University of California, San Francisco OI prophylaxis When to start, when to stop Eva Raphael, MD MPH Family and community medicine, pgy-2 University of California, San Francisco Learning Objectives o Recognize when to start OI prophylaxis

More information

HIV Prevention Pearls

HIV Prevention Pearls HIV Prevention Pearls Meghan Rothenberger, MD Assistant Professor Division of Infectious Diseases University of Minnesota Director, Youth and AIDS Projects October 27, 2017 Disclosure Information I have

More information

HIV and Public Health: the Basics

HIV and Public Health: the Basics HIV and Public Health: the Basics Joy Zeh, RN, MS, Family Nurse Practitioner VCU HIV/AIDS Center HIV and Public Health: the Basics Epidemiology Related Infections and Co-Morbidities Spectrum of HIV Infection

More information

Objectives. HIV in the Trenches HIV Update for the Primary Care Provider, An Overview The HIV Continuum of Care.

Objectives. HIV in the Trenches HIV Update for the Primary Care Provider, An Overview The HIV Continuum of Care. 1:30 2:30pm HIV Update SPEAKER Gordon Dickinson, MD Presenter Disclosure Information The following relationships exist related to this presentation: Gordon Dickinson, MD, has no financial relationships

More information

HIV Surveillance in Urban and Nonurban Areas. National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention

HIV Surveillance in Urban and Nonurban Areas. National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention HIV Surveillance in Urban and Nonurban Areas National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention HIV Infection in Urban and Nonurban Areas Many ways to characterize

More information

Other Diagnostic Tests

Other Diagnostic Tests Other Diagnostic Tests APTIMA HIV-1 RNA Qualitative Assay (approved in Oct 2006) Confirmation test (like Western Blot) Detects RNA of the HIV-1 virus (Nucleic Acid Amplification Test/ NAAT) First test

More information

HIV/AIDS EPIDEMIOLOGY. Rachel Rivera, MD Assistant Professor Infectious Diseases UT Southwestern Medical Center November 14, 2014

HIV/AIDS EPIDEMIOLOGY. Rachel Rivera, MD Assistant Professor Infectious Diseases UT Southwestern Medical Center November 14, 2014 HIV/AIDS EPIDEMIOLOGY Rachel Rivera, MD Assistant Professor Infectious Diseases UT Southwestern Medical Center November 14, 2014 HOUSEKEEPING ANNOUNCEMENTS AUDIO Can you hear us? You will be accessing

More information

HIV Basics for the Family Practitioner Olha Smolynets, DO

HIV Basics for the Family Practitioner Olha Smolynets, DO HIV BASICS FOR FAMILY PRACTITIONER, MS DISCLOSURES Dr. Smolynets has provided no disclosures. OBJECTIVES Indications for HIV screening Prevention counseling Prophylaxis: PrEP, PEP and npep Diagnosis Basic

More information

Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP)

Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) For Healthcare Providers About Emtricitabine/Tenofovir Disoproxil

More information

Diagnosis and Management of Acute HIV

Diagnosis and Management of Acute HIV Diagnosis and Management of Acute HIV A New HIV Diagnosis is a Call to Action In support of the NYSDOH AIDS Institute s January 2018 call to action for patients newly diagnosed with HIV, this committee

More information

Welcome to Carolinas CARE Partnership. HIV A to Z: 6/30/2015. Objectives. The Basics and Beyond. Introductions Pre-Test Expectations

Welcome to Carolinas CARE Partnership. HIV A to Z: 6/30/2015. Objectives. The Basics and Beyond. Introductions Pre-Test Expectations Welcome to Carolinas CARE Partnership HIV A to Z: The Basics and Beyond Introductions Pre-Test Expectations Objectives Distinguish and define HIV and AIDS Brief history of the origin of HIV and AIDS Explain

More information

Clinical Manifestations of HIV

Clinical Manifestations of HIV HIV Symptoms Diane Havlir, MD Professor of Medicine and Chief, HIV/AIDS Division University of California, San Francisco (UCSF) WorldMedSchool; July 2, 2013 1 Clinical Manifestations of HIV! Result from

More information

People who experience gender based violence are more at risk of HIV.

People who experience gender based violence are more at risk of HIV. Know the HIV risk People who experience gender based violence are more at risk of HIV. HIV Human Immunodeficiency Virus is the virus that causes AIDS by interfering with the body s ability to fight off

More information

PrEP in the Real World: Clinical Case Studies

PrEP in the Real World: Clinical Case Studies PrEP in the Real World: Clinical Case Studies Kevin L. Ard, MD, MPH April 30, 2015 Massachusetts General Hospital, National LGBT Health Education Center Continuing Medical Education Disclosure Program

More information

Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. For Healthcare Providers

Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. For Healthcare Providers Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication For Healthcare Providers About TRUVADA for a PrEP Indication INDICATION AND PRESCRIBING CONSIDERATIONS TRUVADA,

More information

INCIDENCE MANAGEMENT OF PATIENTS WITH HIV & AIDS

INCIDENCE MANAGEMENT OF PATIENTS WITH HIV & AIDS MANAGEMENT OF PATIENTS WITH HIV & AIDS http://www.hivtreatmentispower.com/ Timothy Frank MS RN INCIDENCE Worldwide 65 million people infected. In the U.S. December 2008; 1,178,350 people living with HIV

More information

. Presented by UIC-CON

. Presented by UIC-CON . Presented by UIC-CON Upon completion of this training, learners will better able to: Define HIV & AIDS Review the prevalence of HIV/AIDs in the U.S. Explain the transmission, persons at risk, and common

More information

HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body

HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body Melissa Badowski, PharmD, BCPS, AAHIVP Clinical Assistant Professor University

More information

2014 TUBERCULOSIS FACT SHEET A Profile of Mecklenburg County Reported Cases

2014 TUBERCULOSIS FACT SHEET A Profile of Mecklenburg County Reported Cases OVERVIEW T uberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis. TB usually affects the lungs, but it can also affect other parts of the body. TB is spread through the air

More information

HIV. The Role of Pre-Exposure Prophylaxis (PrEP) for the Prevention of HIV. Brief History of HIV AIDS. Global HIV Infection.

HIV. The Role of Pre-Exposure Prophylaxis (PrEP) for the Prevention of HIV. Brief History of HIV AIDS. Global HIV Infection. The Role of Pre-Exposure Prophylaxis (PrEP) for the Prevention of HIV HIV Sarah Kemink, PharmD, AAHIVP WMSHP Spring Seminar 5/05/2015 AIDS CD4 less than 200 +/- AIDS-defining illness Most common: Candidiasis

More information

Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy

Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy 2012 PHYSICIAN QUALITY REPTING OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:

More information

medical monitoring: clinical monitoring and laboratory tests

medical monitoring: clinical monitoring and laboratory tests medical monitoring: clinical monitoring and laboratory tests Purpose of monitoring Check on the physical, psychological and emotional condition of the patient Detect other treatable conditions Identify

More information

Case Studies in PrEP Management. Kevin L. Ard, MD, MPH Massachusetts General Hospital, National LGBT Health Education Center April 15, 2016

Case Studies in PrEP Management. Kevin L. Ard, MD, MPH Massachusetts General Hospital, National LGBT Health Education Center April 15, 2016 Case Studies in PrEP Management Kevin L. Ard, MD, MPH Massachusetts General Hospital, National LGBT Health Education Center April 15, 2016 Continuing Medical Education Disclosure Program Faculty: Kevin

More information

PrEP for Women: HIV Prevention in Family Planning Settings

PrEP for Women: HIV Prevention in Family Planning Settings National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention PrEP for Women: HIV Prevention in Family Planning Settings Dawn K. Smith, MD, MS, MPH Division of HIV/AIDS Prevention dsmith1@cdc.gov

More information

Billing and Coding for HIV Services

Billing and Coding for HIV Services Billing and Coding for HIV Services Financial Disclosure This speaker does not have any financial relationships with commercial entities to disclose. This speaker will not discuss any off-label use or

More information

HIV/AIDS Today: What you need to know when providing services to individuals with HIV/AIDS (Part One) Presented live August 7, 2018

HIV/AIDS Today: What you need to know when providing services to individuals with HIV/AIDS (Part One) Presented live August 7, 2018 HIV/AIDS Today: What you need to know when providing services to individuals with HIV/AIDS (Part One) Presented live August 7, 2018 Mary McCarty-Arias, M.A., CRC More than 25 years experience training

More information

HIV/AIDS Today: What you need to know when providing services to individuals with HIV/AIDS. (Part Two) Presented live August 14, 2018

HIV/AIDS Today: What you need to know when providing services to individuals with HIV/AIDS. (Part Two) Presented live August 14, 2018 HIV/AIDS Today: What you need to know when providing services to individuals with HIV/AIDS (Part Two) Presented live August 14, 2018 Welcome Back! Technical Support 800-263-6317 Mary McCarty-Arias, M.A.,

More information

Presented by: Melissa Egan, Regional Health Education Coordinator, CATIE Date: Tuesday October 8th, 2013, 1 2pm EST

Presented by: Melissa Egan, Regional Health Education Coordinator, CATIE Date: Tuesday October 8th, 2013, 1 2pm EST Presented by: Melissa Egan, Regional Health Education Coordinator, CATIE Date: Tuesday October 8th, 2013, 1 2pm EST Agenda 1. HIV and the immune system 2. The progression of untreated HIV 3. Monitoring

More information

HIV and the Buckeye State

HIV and the Buckeye State HIV and the Buckeye State A Primer Karen Rubin, MPH Senior Community Engagement Coordinator rubin@ohioaidscoalition.org 614-340-6707 HIV 101 WHAT IS HIV? Human- can only infect humans Immunodeficiencyweakens

More information

HIV/AIDS. The Essential Facts

HIV/AIDS. The Essential Facts HIV/AIDS The Essential Facts Educating the Church About HIV/AIDS Over the past decade, limited attention has been paid to the human immunodeficiency virus (HIV) epidemic in the United States. New England

More information

PrEP: Getting to the Tipping Point

PrEP: Getting to the Tipping Point PrEP: Getting to the Tipping Point Harvey J Makadon, MD The National LGBT Health Education Center, The Fenway Institute Professor of Medicine, Harvard Medical School April 15, 2016 Continuing Medical Education

More information

MANAGEMENT OF SEXUAL EXPOSURE TO HIV: PEPSE

MANAGEMENT OF SEXUAL EXPOSURE TO HIV: PEPSE Sandyford Protocols MANAGEMENT OF SEXUAL EXPOSURE TO HIV: PEPSE www.hiv-druginteractions.org If you require information on occupational exposure to blood borne viruses, including HIV, please refer to the

More information

Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University

Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University November 5, 2016 None HIV epidemiology Global U.S. Washington, D.C.

More information

Immunodeficiencies HIV/AIDS

Immunodeficiencies HIV/AIDS Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement

More information

Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know

Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know Carolyn K. Burr, EdD, RN Co-Clinical Director Deputy Director François-Xavier Bagnoud Center December 17 th, 2013

More information

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

On the Horizon for Consideration: Biomedical Advances in HIV Prevention On the Horizon for Consideration: Biomedical Advances in HIV Prevention Francisco Ruiz, MS Senior Manager, National Alliance of State and Territorial AIDS Directors New Jersey Governor's Advisory Council

More information

For People Who Have Been Sexually Assaulted... What You Need To Know about STDs and Emergency Contraception

For People Who Have Been Sexually Assaulted... What You Need To Know about STDs and Emergency Contraception For People Who Have Been Sexually Assaulted... What You Need To Know about STDs and Emergency Contraception FOR PEOPLE WHO HAVE BEEN SEXUALLY ASSAULTED What You Need to Know about STDs and Emergency Contraception

More information

PrEP 201: Beyond the Basics

PrEP 201: Beyond the Basics NORTHWEST AIDS EDUCATION AND TRAINING CENTER PrEP 201: Beyond the Basics Joanne Stekler, MD MPH Associate Professor of Medicine University of Washington February 19, 2015 Disclosures and Disclaimers I

More information

2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California

2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California 2015 OPSC Annual Convention syllabus February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California SUNDAY, FEBRUARY 8, 2015: 10:00am - 11:00am Primary Care of the HIV Patient Presented by Jim Lee,

More information

Disclosure. Learning Objectives. Epidemiology. Transmission. Risk of Transmission PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION 50,000.

Disclosure. Learning Objectives. Epidemiology. Transmission. Risk of Transmission PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION 50,000. Disclosure PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION I have no financial interest in and/or affiliation with any external organizations in relation to this CE program. DaleMarie Vaughan, PharmD

More information

HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland. An update for registered practitioners September 2017

HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland. An update for registered practitioners September 2017 HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland An update for registered practitioners September 2017 Key Messages HIV is a major public health challenge for Scotland with an annual average of 359

More information

OR: Steps you can take in the clinic to prevent HIV infections

OR: Steps you can take in the clinic to prevent HIV infections Implementing Changes to Reduce HIV Incidence: Synergies between Public Health and Primary Care Kevin Ard, MD, MPH Brigham and Women s Hospital, Massachusetts General Hospital, and the Fenway Institute

More information

LET S TALK about Sticking with your treatment plan

LET S TALK about Sticking with your treatment plan LET S TALK about Sticking with your treatment plan HOW ONGOING HIV CARE HELPS YOU LIVE A LONGER AND HEALTHIER LIFE Your treatment plan is vital to your overall health (and to reducing HIV transmission)

More information

Moving beyond condoms to prevent HIV transmission. Are you Prepared for HIV PrEP?

Moving beyond condoms to prevent HIV transmission. Are you Prepared for HIV PrEP? Moving beyond condoms to prevent HIV transmission Are you Prepared for HIV PrEP? The Issues New HIV infections in the US continue Vast majority of infections are sexually acquired Condoms work but are

More information

Action Item for 2019 Review of Tool. Maintain (add include oral cavity) Maintain. Archive. Archive. 12 creatinine)

Action Item for 2019 Review of Tool. Maintain (add include oral cavity) Maintain. Archive. Archive. 12 creatinine) NEWLY DIAGNOSED/ NEW TO CARE PROGRAM SITE: REVIEWER(S): REVIEW DATE: CORE SERVICES Outpatient/Ambulatory Health Services Tool - 2018 (OLD) SECTION 1: CHART REVIEW Review for newly diagnosed HIV patients

More information

HIV/AIDS MEASURES GROUP OVERVIEW

HIV/AIDS MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: HIV/AIDS MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN HIV/AIDS MEASURES GROUP: #159. HIV/AIDS: CD4+ Cell Count or CD4+ Percentage Performed #160. HIV/AIDS: Pneumocystis

More information

HIV & THE MEDICAL HOME A NEW FRONT FOR GETTING TO ZERO. Brent K. Sugimoto, MD, MPH Kaiser Permanente. 29th Annual East Bay HIV Update June 3, 2016

HIV & THE MEDICAL HOME A NEW FRONT FOR GETTING TO ZERO. Brent K. Sugimoto, MD, MPH Kaiser Permanente. 29th Annual East Bay HIV Update June 3, 2016 HIV & THE MEDICAL HOME A NEW FRONT FOR GETTING TO ZERO 29th Annual East Bay HIV Update June 3, 2016 Brent K. Sugimoto, MD, MPH Kaiser Permanente Photo Credit: C. GoldsmithContent Providers: CDC/ C. Goldsmith,

More information

What Does HIV Do to You?

What Does HIV Do to You? What Does HIV Do to You? HIV and the immune system Your immune system is supposed to protect you from viruses and other infections. Why, then, doesn t it protect you from HIV? The answer is complicated,

More information

HIV basics. Katya Calvo Medical Director of Antimicrobial Stewardship

HIV basics. Katya Calvo Medical Director of Antimicrobial Stewardship HIV basics Katya Calvo Medical Director of Antimicrobial Stewardship Learning Objectives 1. Review of HIV epidemiology worldwide and locally 2. Review of recommendations on whom to screen 3. Work up of

More information

Women s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins

Women s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins Women s Sexual Health: STI and HIV Screening Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins I have no disclosures! Review most recent rates of STIs and HIV across the

More information

Finding the Positives: Routine HIV Testing and Prevention

Finding the Positives: Routine HIV Testing and Prevention Finding the Positives: Routine HIV Testing and Prevention Pennsylvania Nurse Practitioner Coalition Conference Friday November 4, 2016 NELLIE RIENDEAU LAZAR, MSN, CRNP, AAHIVM CHILDREN S HOSPITAL OF PHILADELPHIA

More information

Medical Overview March 7, Nina Lambert, NP Inova Juniper Program

Medical Overview March 7, Nina Lambert, NP Inova Juniper Program Medical Overview March 7, 2019 Nina Lambert, NP Inova Juniper Program Nina.lambert@inova.org Inova Juniper Program Sites Offering medical care, case management and mental health for youth and adults who

More information

San Francisco AIDS Cases Reported Through December 31, 1998

San Francisco AIDS Cases Reported Through December 31, 1998 San Francisco AIDS Cases Reported Through December 31, 1998 San Francisco Department of Public Health HIV Seroepidemiology and Surveillance Section AIDS Surveillance Unit Contents Page Commentary: Trends

More information

http://www.savinglivesuk.com/ HIV Awareness Study Morning 24 th November 2017 Agenda HIV Basics & Stages of HIV HIV Testing, Health Advising & Sexual Health Saving Lives Antiretroviral Medication Antenatal/Postnatal

More information

Trends in HIV Incidence and Prevalence in the United States

Trends in HIV Incidence and Prevalence in the United States Trends in HIV Incidence and Prevalence in the United States Irene Hall, PhD, FACE 7th International Workshop on HIV Transmission Washington, DC, July 20, 2012 National Center for HIV/AIDS, Viral Hepatitis,

More information

HIV/AIDS. Communication and Prevention. Davison Community Schools Grade Six June 2018

HIV/AIDS. Communication and Prevention. Davison Community Schools Grade Six June 2018 HIV/AIDS Communication and Prevention Davison Community Schools Grade Six June 2018 Discussing Sensitive Matters with Your Parents Parents: A child s first and most important teacher Parent s role is to

More information

HIV/AIDS Epidemiology in Alameda County: State of the County Report

HIV/AIDS Epidemiology in Alameda County: State of the County Report Lake Merritt, Oakland,California HIV/AIDS Epidemiology in Alameda County: State of the County Report Muntu Davis, MD, MPH County Health Officer and Public Health Director Alameda County White House Office

More information

Pre-exposure Prophylaxis and Primary Care

Pre-exposure Prophylaxis and Primary Care Pre-exposure Prophylaxis and Primary Care National Latino HIV and Hepatitis C Conference June 7 th, 2016 Allison Finkenbinder, MSN, WHNP-BC Denver Prevention Training Center Who s in the audience? Disclosures

More information

I M ENDING HIV PATIENT INFORMATION. endinghiv.org.au/prep

I M ENDING HIV PATIENT INFORMATION. endinghiv.org.au/prep I M ENDING HIV PrEP PATIENT INFORMATION endinghiv.org.au/prep THIS BOOKLET PROVIDES YOU WITH INFORMATION ABOUT Pre-Exposure Prophylaxis (PrEP) for HIV. CONTENTS 06 Who will benefit from PrEP? 04 What is

More information

TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. Training Guide for Healthcare Providers

TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. Training Guide for Healthcare Providers TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication Training Guide for Healthcare Providers About TRUVADA for a PrEP indication to reduce the risk of sexually acquired HIV-1 infection in high-risk

More information

HIV In The Navy and Marine Corps A Discussion For Health Care Professionals 2 December 2013

HIV In The Navy and Marine Corps A Discussion For Health Care Professionals 2 December 2013 HIV In The Navy and Marine Corps A Discussion For Health Care Professionals 2 December 2013 The views expressed in this briefing are those of the author and do not necessarily reflect the official policy

More information

Truth THE STORY OF HIV/ CONSEQUENCE. Women's Ministries Department General Conference of Seventh-day Adventists

Truth THE STORY OF HIV/ CONSEQUENCE. Women's Ministries Department General Conference of Seventh-day Adventists Truth OR CONSEQUENCE THE STORY OF HIV/ AIDS Women's Ministries Department General Conference of Seventh-day Adventists What is? HIV (Human Immunodeficiency Virus) is a virus that causes AIDS (Acquired

More information

A guide for hospitals & healthcare facilities in rural areas

A guide for hospitals & healthcare facilities in rural areas Prescribing npep A guide for hospitals & healthcare facilities in rural areas This infographic provides recommendations for prescribing non-occupational post-exposure prophylaxis (npep) at rural healthcare

More information

8/10/2017. HIV UPDATE 2017 David M Stein DO, FACOI

8/10/2017. HIV UPDATE 2017 David M Stein DO, FACOI HIV UPDATE 2017 David M Stein DO, FACOI 1 Current US HIV data 1.1 million HIV positive 1 out of 7 positive are unaware of their status Highest risk in Gay and Bisexual men, young African American men 2

More information

INITIATING ART IN CHILDREN: Follow the six steps

INITIATING ART IN CHILDREN: Follow the six steps INITIATING ART IN CHILDREN: Follow the six steps STEP 1: DECIDE IF THE CHILD HAS CONFIRMED HIV INFECTION Child < 18 months: HIV infection is confirmed if the PCR is positive and the VL is more than 10,000

More information

Testing for HIV in Practice - Seminar. Case History. 19 year old black African patient registered with the practice 5 years (since age 14).

Testing for HIV in Practice - Seminar. Case History. 19 year old black African patient registered with the practice 5 years (since age 14). Joint RCGP / BHIVA Multidisciplinary Conference HIV in Primary Care: All you need to know Friday 25 January 2013 Friday 25 January 2013, Royal College of General Practitioners, London HIV in Primary Care

More information

ONLY IN HUMANS! CAN GET SICK FASTER. What is HIV? NO CURE. Human Immunodeficiency Virus. HIV ATTACKS your T-cells. And uses them to of itself

ONLY IN HUMANS! CAN GET SICK FASTER. What is HIV? NO CURE. Human Immunodeficiency Virus. HIV ATTACKS your T-cells. And uses them to of itself The 411: HIV ONLY IN HUMANS! CAN GET SICK FASTER What is HIV? NO CURE Human Immunodeficiency Virus HIV ATTACKS your T-cells And uses them to of itself HIV Progression Acute Infection Stage Clinical Latency

More information

STIs in the Indian Country

STIs in the Indian Country STIs in the Indian Country Multiple STI s and Risk for HIV Ryan Kreisberg, MPH Senior Epidemiologist, PRISM Data Manager Agenda STI/HIV Trends across the US and Arizona STIs in the Indian Country Multiple

More information

Anti Retroviral Traitment (ARVs)

Anti Retroviral Traitment (ARVs) Anti Retroviral Traitment (ARVs) IEC material for People With Disabilities UPHLS - 2015 - Anti Retroviral Traitment Booklet Produced by AZ MEDIA No part of this publication may be reproduced without prior

More information

Implementing HIV Screening at Hub and Spoke Sites and Other Drug Treatment Settings

Implementing HIV Screening at Hub and Spoke Sites and Other Drug Treatment Settings Implementing HIV Screening at Hub and Spoke Sites and Other Drug Treatment Settings Dennis Fleming, MA CDPH/Office of AIDS DHCS Statewide SUD Conference August 23, 2018 Anaheim, CA Agenda What s New in

More information

The Faith in Prevention Training Manual: Tools for Your HIV/AIDS Ministry A faith-based model of partnership to stop HIV

The Faith in Prevention Training Manual: Tools for Your HIV/AIDS Ministry A faith-based model of partnership to stop HIV The Faith in Prevention Training Manual: Tools for Your HIV/AIDS Ministry A faith-based model of partnership to stop HIV My people perish for lack of knowledge Hosea 4:6a Developed By Starr Smith Adler

More information

Cleveland Prevention Update. Zach Reau HIV Prevention Program Manager Ohio Department of Health

Cleveland Prevention Update. Zach Reau HIV Prevention Program Manager Ohio Department of Health Cleveland Prevention Update Zach Reau HIV Prevention Program Manager Ohio Department of Health May 21-22, 2018 ODH HIV PREVENTION PROGRAM 2018-2019 Overview Client Services Team Client Services Administrator-

More information

An International Antiviral Society-USA

An International Antiviral Society-USA Doug Campos-Outcalt, MD, MPA University of Arizona, Phoenix dougco@email.arizona. edu A look at new guidelines for HIV treatment and prevention Start antiretroviral therapy as soon as possible after HIV

More information

The HIV Prevention Pill: The State of PrEP Science and Implementation. James Wilton Coordinator, Biomedical Science of HIV Prevention CATIE

The HIV Prevention Pill: The State of PrEP Science and Implementation. James Wilton Coordinator, Biomedical Science of HIV Prevention CATIE The HIV Prevention Pill: The State of PrEP Science and Implementation James Wilton Coordinator, Biomedical Science of HIV Prevention CATIE Overview 1. The Basics 2. A review of the science 3. An update

More information

Using PrEP as Harm Reduction. Iman Little, MPH Team Lead, Preventative Services Chicago Center for HIV Elimination

Using PrEP as Harm Reduction. Iman Little, MPH Team Lead, Preventative Services Chicago Center for HIV Elimination Be PrEPared! Using PrEP as Harm Reduction Iman Little, MPH Team Lead, Preventative Services Chicago Center for HIV Elimination Ricky Hill, MA, PhD candidate Team Lead, Community Partnerships and Engagement

More information

Pre-Exposure Prophylaxis (PrEP) for HIV Infection

Pre-Exposure Prophylaxis (PrEP) for HIV Infection Pre-Exposure Prophylaxis (PrEP) for HIV Infection Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Attending Physician UCLA Center AIDS Research

More information

HIV and the Young Adult. Laura Rachal, MD MS Tulane Internal Medicine-Pediatrics, PGY4 LAAP Potpurri Meeting August 19, 2018

HIV and the Young Adult. Laura Rachal, MD MS Tulane Internal Medicine-Pediatrics, PGY4 LAAP Potpurri Meeting August 19, 2018 HIV and the Young Adult Laura Rachal, MD MS Tulane Internal Medicine-Pediatrics, PGY4 LAAP Potpurri Meeting August 19, 2018 Disclosure Slide I have no actual or potential conflict of interest in relation

More information

HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS. Speaker: Susan MK Lee, PharmD, BCPS, CDE

HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS. Speaker: Susan MK Lee, PharmD, BCPS, CDE Clinical Education Initiative Support@ceitraining.org HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS Speaker: Susan MK Lee, PharmD, BCPS, CDE 12/13/2016 HIV Prevention with Pre-Exposure

More information

If you are a man that ONLY has sex with women this may not be the brochure for you.

If you are a man that ONLY has sex with women this may not be the brochure for you. If you are a man that ONLY has sex with women this may not be the brochure for you. To find resources that best meet your needs check out the following website: http://www.cdc.gov/men Whether you are gay,

More information

Strategic use of antiretroviral drugs to prevent HIV transmission

Strategic use of antiretroviral drugs to prevent HIV transmission Strategic use of antiretroviral drugs to prevent HIV transmission 22th Tunisian Congress of Infectious Diseases 2nd Congress of Federation of Arab Societies of Clinical Microbiology and Infectious Diseases

More information

NURSING CARE FOR PLWHIV

NURSING CARE FOR PLWHIV NURSING CARE FOR PLWHIV Eva Mureithi, RN ACRN Sheka Jones, BSN, MPH, ACRN Bay Area and North Coast AIDS Education and Training Center May 11th 2018 1 Learning Objectives After attending this session, you

More information

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS Human Immunodeficiency Virus Acquired Immune Deficiency Syndrome AIDS Sudden outbreak in USA of opportunistic infections and cancers in young men in 1981 Pneumocystis carinii pneumonia (PCP), Kaposi s

More information

Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Training Guide for Healthcare Providers

Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Training Guide for Healthcare Providers Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Training Guide for Healthcare Providers About emtricitabine/tenofovir disoproxil fumarate for HIV-1 PrEP

More information

Multiple choice questions: ANSWERS

Multiple choice questions: ANSWERS Multiple choice questions: ANSWERS Chapter 1. Diagnosis and promotion of serostatus awareness in sub-saharan Africa 1. Antiretroviral therapy reduces HIV transmission from a HIV- positive person to a susceptible

More information

Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84

Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84 Clinical guidelines across THE CONTINuUM OF CARE: LINKING PEOPLE DIAGNOSEd WiTH hiv infection to hiv care and treatment 06 6.1 Introduction 84 6.2 Good practices for linkage to care 84 6.3 General care

More information

0% 0% 0% Parasite. 2. RNA-virus. RNA-virus

0% 0% 0% Parasite. 2. RNA-virus. RNA-virus HIV/AIDS and Treatment Manado, Indonesia 16 november HIV [e] EDUCATION HIV is a 1. DNA-virus 2. RNA-virus 3. Parasite 0% 0% 0% DNA-virus RNA-virus Parasite HIV HIV is a RNA-virus. HIV is an RNA virus which

More information

Communicable Diseases

Communicable Diseases Communicable Diseases Communicable diseases are ones that can be transmitted or spread from one person or species to another. 1 A multitude of different communicable diseases are currently reportable in

More information

Didactic Series. Primary HIV Infection. Greg Melcher, M.D. UC Davis AETC 8 Nov 2012

Didactic Series. Primary HIV Infection. Greg Melcher, M.D. UC Davis AETC 8 Nov 2012 Didactic Series Primary HIV Infection Greg Melcher, M.D. UC Davis AETC 8 Nov 2012 ACCREDITATION STATEMENT: University of California, San Diego School of Medicine is accredited by the Accreditation Council

More information

Trends in Reportable Sexually Transmitted Diseases in the United States, 2007

Trends in Reportable Sexually Transmitted Diseases in the United States, 2007 Trends in Reportable Sexually Transmitted Diseases in the United States, 2007 National Surveillance Data for Chlamydia, Gonorrhea, and Syphilis Sexually transmitted diseases (STDs) remain a major public

More information

When to start: guidelines comparison

When to start: guidelines comparison The editorial staff When to start: guidelines comparison The optimal time to begin antiretroviral therapy remains a critical question for the HIV field, and consensus about the appropriate CD4+ cell count

More information

Biomedical HIV Prevention & PrEP Pre exposure Prophylaxis 2013

Biomedical HIV Prevention & PrEP Pre exposure Prophylaxis 2013 Biomedical HIV Prevention & PrEP Pre exposure Prophylaxis 2013 Community Education Team The AIDS Institute/AIDS Alliance Be the Generation to End the AIDS Epidemic bethegeneration.nih.gov www.aids-alliance.org/education/vaccine

More information

HIV Testing and HIV Prevention

HIV Testing and HIV Prevention HIV Testing and HIV Prevention Five Things to Know: Essentials of HIV Prevention Webinar 2 Primary Care Development Corporation Five Things to Know: Essentials of HIV Prevention Social Marketing and HIV

More information

HIV Screening in Behavioral Health Settings: The Need is Clear

HIV Screening in Behavioral Health Settings: The Need is Clear HIV Screening in Behavioral Health Settings: The Need is Clear Alyssa A. Bittenbender, MPH Program Director, Arizona AIDS Education and Training Center University of Arizona College of Medicine MISSION

More information

PrEP application in the SA Context. Dr Kevi Naidu AWACC 07Oct2016

PrEP application in the SA Context. Dr Kevi Naidu AWACC 07Oct2016 PrEP application in the SA Context Dr Kevi Naidu AWACC 07Oct2016 Definition: Key Populations o Key populations are: Defined groups who, due to specific higher-risk behaviours, are Men at who increased

More information

Important Safety Information for Adolescents Who Don t Have HIV

Important Safety Information for Adolescents Who Don t Have HIV Important Safety Information for Adolescents Who Don t Have HIV This booklet tells you about: HIV The medicine emtricitabine/tenofovir disoproxil fumarate for HIV-1 PrEP What you need to do while taking

More information